 Eidos Therapeutics Inc NASDAQ:EIDX has earned a consensus recommendation of Hold from the ten brokerages that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and six have given a buy recommendation to the company. The average 1 year price ... 